A grandmother, diagnosed with breast cancer, and her toddler granddaughter, diagnosed with acute myeloid leukemia, are facing ...

Allogene Therapeutics has dropped plans to target one of its allogeneic CAR-Ts at leukemia in the face of competition from ...

The VA launched its own internal process in 2021 to determine whether health conditions may be considered related to military ...

Danziten, a new formulation of nilotinib, may improve treatment adherence in patients with Philadelphia chromosome-positive ...

The U.S. Food and Drug Administration on Friday approved Syndax Pharmaceuticals' drug for the treatment of adult and ...

NEW YORK — NBA referee Scott Wall was diagnosed with acute myeloid leukemia earlier this year and is in treatment, the ...

Allogene is ceasing enrollment in a Phase I trial of cema-cel for patients with relapsed or refractory chronic lymphocytic ...

NBA referee Scott Wall was diagnosed with acute myeloid leukemia earlier this year and is in treatment, the National ...

Revuforj was approved by the FDA for adults and children with relapsed/refractory acute leukemia with a KMT2A translocation.

The FDA has granted approval to Azurity Pharmaceuticals' nilotinib tablets (Danziten), a novel version of the tyrosine kinase ...

Leukemia & Lymphoma Society raises $1.4M in annual 'Light The Night' fundraising campaign This past weekend, LA came together ...